Recently Viewed

News Announcement

Marksans Pharma: Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome

16-Nov-2022 Follow Value Research Online on Google download pdfDownload PDF Marksans Pharma

Pursuant to Regulation 30 read with Part A of Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 the audio recording of the Q2FY23 & H1FY23 Results Conference Call is hosted on the website of the Company under the following link: http://marksanspharma.com/investors-meet.htmI

Ask Value Research aks value research information

No question is too small. Share your queries on personal finance, mutual funds, or stocks and let us simplify things for you.

Mutual Fund Insight turns 24! 🎉 Get 2 FREE anniversary guides: The Right SIP + The Big Funds